Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).
about
The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancerCDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression.miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation.Pharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer.Investigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016).Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets.CDK5 in oncology: recent advances and future prospects.
P2860
Q26751387-1341C080-6DF3-48D2-B633-1ED036C0E949Q36962507-129C3D1A-90D0-45DB-B3A9-CDB8503134FCQ37085995-B9F6E5F4-5F64-4F8D-983A-2FC9114B036AQ38743546-C2204D70-E35D-44B0-B5B3-82927F2A62B3Q38949247-4A923ABD-6A38-4D8A-9C26-0A662290854BQ47393972-D18AAC77-43CD-4372-B7EF-45861EE3C5F0Q47873426-4A948D3B-CBF3-46C8-B164-DA1A2160A291
P2860
Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).
@en
type
label
Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).
@en
prefLabel
Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).
@en
P2860
P1476
Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).
@en
P2093
Jakub Vylíčil
P2860
P304
P356
10.1517/13543776.2015.1045414
P407
P577
2015-07-10T00:00:00Z